Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Reviving drugs with anti-stroke potential, minus side effects

  • Shake it off? Not so easy for people with depression, new brain research suggests

  • Protein pathway involved in brain tumor stem cell growth identified

  • Enhancing studies on a possible blood biomarker for traumatic brain injury

  • Left or right? The brain knows before you move

  • Study challenges theory on unconscious memory system in the brain

  • Study challenges theory on unconscious memory system

  • Retinal swelling in premature infants tied to poorer neuro-development

  • Intermediary neuron acts as synaptic cloaking device

  • Method for mapping neuron clusters developed

  •